Skip Navigation LinksHome > February 2008 - Volume 21 - Issue 1 > Perioperative β-blocker and statin therapy
Current Opinion in Anaesthesiology:
doi: 10.1097/ACO.0b013e3282f35ea5
Cardiovascular anaesthesia: Edited by Stefan De Hert

Perioperative β-blocker and statin therapy

Daumerie, Geraldine; Fleisher, Lee A

Collapse Box


Purpose of review: Perioperative β-blockade and statin therapy have been advocated to reduce cardiac risk of noncardiac surgery. This review evaluates recent articles published on the cardioprotective effects of perioperative therapy with these medications.

Recent findings: Initial studies evaluating β-blocker therapy during the perioperative period suggested that β-blockers may be beneficial in reducing cardiac deaths and myocardial infarctions. Later studies and recent meta-analyses, however, are less favorable and suggest that β-blockers may be associated with increased incidence of bradycardia and hypotension. One randomized trial and several cohort studies have found a significant reduction in cardiovascular complications with perioperative statin therapy. Additionally, statin withdrawal is associated with increased postoperative cardiac risk.

Summary: Based upon the available evidence and guidelines, patients currently taking β-blockers should continue these agents. Patients undergoing vascular surgery who are at high cardiac risk should also take β-blockers. The question remains regarding the best protocol to initiate perioperative β-blockade. Statins should be continued in patients already taking these agents prior to surgery. The optimal duration and time of initiation of statin therapy remains unclear.

© 2008 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.